文献速递血栓与止血

间充质干细胞缺陷通过TNFAIP3/NF-κB/SMAD通路影响免疫性血小板减少症患者的巨核细胞生成

Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2018-01-12

该研究探讨免疫性血小板减少症(ITP)患者间充质干细胞(MSC)中TNFAIP3/NF-κB/SMAD通路对巨核细胞生成的影响。结果显示ITP-MSC中TNFAIP3降低、NF-κB/SMAD7升高,且ITP-MSC支持CD34+细胞巨核细胞分化和血小板生成的能力受损;敲低IKBKB、过表达TNFAIP3或敲低SMAD7可纠正上述缺陷。

要点

  • ITP患者MSC中TNFAIP3表达降低、NF-κB/SMAD7表达升高。
  • ITP-MSC支持CD34+细胞巨核细胞分化和血小板生成的能力受损。
  • 敲低IKBKB、过表达TNFAIP3或敲低SMAD7可纠正ITP-MSC的功能缺陷。

核心结论

  • ITP患者MSC中TNFAIP3水平病理性降低诱导NF-κB/SMAD7通路激活,导致MSC缺陷。
  • ITP-MSC支持CD34+细胞巨核细胞分化和血小板生成的能力受损。

研究设计与样本

  • 研究比较ITP患者与健康对照的MSC,并通过shRNA或cDNA转染在体外共培养体系中调控TNFAIP3、NFKBIA、IKBKB和SMAD7表达。

主要发现

  • ITP-MSC中TNFAIP3表达显著降低,NF-κB/SMAD7表达显著升高。
  • 健康对照MSC转染NFKBIA特异性shRNA后NF-κB过表达,导致MSC缺陷并减少巨核细胞分化和血小板生成。
  • 健康对照MSC敲低TNFAIP3表达影响巨核细胞生成。
  • ITP-MSC敲低IKBKB通过降低NF-κB表达纠正巨核细胞生成抑制。
  • ITP-MSC过表达TNFAIP3或敲低SMAD7可促进巨核细胞分化或挽救受损的MSC功能。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune thrombocytopenia (ITP) is an autoimmune disease. Mesenchymal stem cells (MSCs) play important roles in the physiology and homeostasis of the haematopoietic system, including supporting megakaryocytic differentiation from CD34+ haematopoietic progenitor cells. Tumour necrosis factor alpha-induced protein 3 (TNFAIP3, also termed A20) plays a key role in terminating NF-κB signalling. Human genetic studies showed that the polymorphisms of the TNFAIP3 gene may contribute to ITP susceptibility. In this study, we showed a significant decrease in TNFAIP3 and increase in NF-κB/SMAD7 in ITP-MSCs. In co-cultures with CD34+ cells, NF-κB was overexpressed in MSCs from healthy controls (HC-MSCs) after transfection with NFKBIA (IκB)-specific short hairpin (sh)RNAs, resulting in MSC deficiency and a reduction in megakaryocytic differentiation and thrombopoiesis. Knockdown of TNFAIP3 expression using TNFAIP3-specific shRNAs in HC-MSCs affected megakaryocytopoiesis. However, IKBKB knockdown corrected megakaryocytopoiesis inhibition in the ITP-MSCs by decreasing NF-κB expression. Amplified TNFAIP3 expression in ITP-MSCs by TNFAIP3 cDNA can facilitate megakaryocyte differentiation. shRNA-mediated knockdown of SMAD7 expression rescued the impaired MSC function in ITP patients. Therefore, we demonstrate that a pathological reduction in TNFAIP3 levels induced NF-κB/SMAD7 pathway activation, causing a deficiency in MSCs in ITP patients. The ability of ITP-MSCs to support megakaryocytic differentiation and thrombopoiesis of CD34+ cells was impaired.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. He Y, Xu LL, Feng FE, et al. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia. Br J Haematol. 2018. PMID: 29327472. doi:10.1111/bjh.15034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。